Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LABRADOR: Doravirine pharmacokinetics in HIV patients undergoing bariatric surgery
2021-005347-79Phase 4Terminated
- Sponsor
- Radboud University Medical Center
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of doravirine in Human immunodeficiency virus infection type 1, sponsored by Radboud University Medical Center. Primary endpoints: Doravirine PK after bariatric surgery and Safety of doravirine around bariatric surgery. Started Feb 2022; status: terminated.
02
Drugs
doravirine
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2021-005347-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005347-79.